Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#InnovationInHealth

Home » #InnovationInHealth
AIDS Exclusive Interview | AMP Trial: Successes and Breakthroughs in HIV Prevention

AIDS Exclusive Interview | AMP Trial: Successes and Breakthroughs in HIV Prevention

Posted by By Peng Longmei 2024.10.14
Editor's Note: The breakthrough results from the Antibody Mediated Prevention (AMP) trials have revitalized global public health efforts in the field of HIV prevention. At the AIDS 2024 conference, Dr.…
Read More
Shitong Huan: Improving Health Systems and Innovating Diagnostic and Treatment Tools to Eliminate Tuberculosis丨15th Tuberculosis Eastern Forum

Shitong Huan: Improving Health Systems and Innovating Diagnostic and Treatment Tools to Eliminate Tuberculosis丨15th Tuberculosis Eastern Forum

Posted by By Mourabit Halima 2024.10.08
Editor's Note: Humanity has coexisted with tuberculosis for over 5,000 years. It claimed the lives of renowned figures like Shelley, Empress Sisi, and Lu Xun. Ending the "white plague" is…
Read More
Recent Posts
  • Highlights from the 13th International Conference of the Federation of Asian Clinical Oncology (FACO 2025)
  • ESMO China Voice | Professor Jiesong Wang: The iPET-NCCN-IPI Model May Optimize Risk Stratification in Diffuse Large B-Cell Lymphoma
  • ESMO China Voice | Dr. Sicong Zhang: Refractory DLBCL Patients Share Similar Immune Signatures
  • ESMO China Voice | Dr. Cong Sun: Grade 3B Follicular Lymphoma Is an Independent Risk Factor Affecting Both PFS and OS
  • ESMO China Voice | Prof. Liang Wang: CD19/CD22 Bispecific CAR-T Therapy Demonstrates Remarkable Efficacy and Safety in R/R LBCL
Recent Comments
    Archives
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司（香港）
    Scroll to Top